According to Syndax Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -NZ$0.44 B. In 2023 the company made an earning of -NZ$0.35 B a decrease over its 2022 earnings that were of -NZ$0.25 B.The earnings displayed on this page is the company's Pretax Income.